Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication. 2005

Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
Valeant Pharmaceuticals International, 3300 Hyland Avenue Costa Mesa, CA 92626, USA. yding@icnpharm.com

A series of 9-(2'-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives were synthesized as potential inhibitors of HCV RNA replication. Their inhibitory activities in a cell based HCV replicon assay were reported. A prodrug approach was used to further improve the potency of these compounds by increasing the intracellular levels of 5'-monophosphate metabolites. These nucleotide prodrugs showed much improved inhibitory activities of HCV RNA replication.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
March 2004, Bioorganic & medicinal chemistry,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
February 1973, Biochemical pharmacology,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
March 2014, ACS medicinal chemistry letters,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
April 2000, Nucleosides, nucleotides & nucleic acids,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
March 1970, The Journal of organic chemistry,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
January 2016, ACS medicinal chemistry letters,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
October 1986, Journal of medicinal chemistry,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
December 1969, Biochimica et biophysica acta,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
April 1965, Journal of the American Chemical Society,
Yili Ding, and Jean-Luc Girardet, and Zhi Hong, and Vicky C H Lai, and Haoyun An, and Yung-Hyo Koh, and Stephanie Z Shaw, and Weidong Zhong
January 2003, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!